Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Matthew R. Smith(Massachusetts General Hospital), Fred Saad(Université de Montréal), Robert E. Coleman(Weston Park Cancer Centre), Neal D. Shore(Carolina Urologic Research Center), Karim Fizazi(Institut Gustave Roussy), Bertrand Tombal(UCLouvain), Kurt Miller(Charité - Universitätsmedizin Berlin), Paul Sieber(Urology Associates), Lawrence I. Karsh(The Urology Center of Colorado), Ronaldo Damião(Hospital Universitário Pedro Ernesto), Teuvo L.J. Tammela(Tampere University Hospital), Blair Egerdie, Hendrik Van Poppel(Universitair Ziekenhuis Leuven), Joseph L. Chin(London Health Sciences Centre), Juan Moróte(Vall d'Hebron Hospital Universitari), F. Gómez-Veiga(Complexo Hospitalario Universitario A Coruña), Tomasz Borkowski(Szpital Kliniczny Dzieciątka Jezus), Zhishen Ye(Amgen (United States)), Amy Kupic(Amgen (United States)), Roger Dansey(Amgen (United States)), Carsten Goessl(Amgen (United States))
Cited by 795Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis